Affinity DataKi: 3.5nMAssay Description:Compound was evaluated for its binding affinity against HIV-1 protease using [125I]-SPA (scintillation proximity assay)More data for this Ligand-Target Pair
Affinity DataKi: 1.60E+3nMAssay Description:Inhibition of GSK3beta (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: 3nMAssay Description:Inhibitory activity against HIV-1 proteaseMore data for this Ligand-Target Pair
Affinity DataIC50: 5nMAssay Description:Inhibitory activity against HIV-1 proteaseMore data for this Ligand-Target Pair
Affinity DataIC50: 5nMAssay Description:Inhibitory activity against HIV-1 proteaseMore data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:Inhibitory activity against HIV-1 proteaseMore data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:Inhibitory activity against HIV-1 proteaseMore data for this Ligand-Target Pair
Affinity DataIC50: 30nMAssay Description:Inhibitory activity against HIV-1 proteaseMore data for this Ligand-Target Pair
Affinity DataIC50: 30nMAssay Description:Concentration required for inhibitory activity against HIV-1 ProteaseMore data for this Ligand-Target Pair
Affinity DataIC50: 30nMAssay Description:Concentration required for inhibitory activity against HIV-1 ProteaseMore data for this Ligand-Target Pair
Affinity DataIC50: 30nMAssay Description:Concentration required for inhibitory activity against HIV-1 ProteaseMore data for this Ligand-Target Pair
Affinity DataIC50: 30nMAssay Description:Concentration required for inhibitory activity against HIV-1 ProteaseMore data for this Ligand-Target Pair
Affinity DataIC50: 30nMAssay Description:Concentration required for inhibitory activity against HIV-1 ProteaseMore data for this Ligand-Target Pair
Affinity DataIC50: 40nMAssay Description:Compound was tested for inhibitory activity against recombinant HIV-1 protease using 125 I-SPA (scintillation proximity assay)More data for this Ligand-Target Pair
Affinity DataIC50: 45nMAssay Description:Compound was tested for inhibitory activity against recombinant HIV-1 protease using 125 I-SPA (scintillation proximity assay)More data for this Ligand-Target Pair
Affinity DataIC50: 70nMAssay Description:Concentration required for inhibitory activity against HIV-1 ProteaseMore data for this Ligand-Target Pair
Affinity DataIC50: 70nMAssay Description:Concentration required for inhibitory activity against HIV-1 ProteaseMore data for this Ligand-Target Pair
Affinity DataIC50: 70nMAssay Description:Concentration required for inhibitory activity against HIV-1 ProteaseMore data for this Ligand-Target Pair
Affinity DataIC50: 75nMAssay Description:Inhibitory activity against HIV-1 proteaseMore data for this Ligand-Target Pair
Affinity DataIC50: 80nMAssay Description:Concentration required for inhibitory activity against HIV-1 ProteaseMore data for this Ligand-Target Pair
Affinity DataIC50: 90nMAssay Description:Inhibitory activity against HIV-1 proteaseMore data for this Ligand-Target Pair
Affinity DataIC50: 130nMAssay Description:Concentration required for inhibitory activity against HIV-1 ProteaseMore data for this Ligand-Target Pair
Affinity DataIC50: 140nMAssay Description:Concentration required for inhibitory activity against HIV-1 ProteaseMore data for this Ligand-Target Pair
Affinity DataIC50: 150nMAssay Description:Concentration required for inhibitory activity against HIV-1 ProteaseMore data for this Ligand-Target Pair
Affinity DataIC50: 250nMAssay Description:Concentration required for inhibitory activity against HIV-1 ProteaseMore data for this Ligand-Target Pair
Affinity DataIC50: 350nMAssay Description:Compound was tested for inhibitory activity against recombinant HIV-1 protease using 125 I-SPA (scintillation proximity assay)More data for this Ligand-Target Pair
Affinity DataIC50: 400nMAssay Description:Compound was tested for inhibitory activity against recombinant HIV-1 protease using 125 I-SPA (scintillation proximity assay)More data for this Ligand-Target Pair
Affinity DataIC50: 400nMAssay Description:Inhibitory activity against HIV-1 proteaseMore data for this Ligand-Target Pair
Affinity DataIC50: 450nMAssay Description:Compound was evaluated for its inhibitory activity in recombinant HIV-l proteaseMore data for this Ligand-Target Pair
Affinity DataIC50: 600nMAssay Description:Compound was tested for inhibitory activity against recombinant HIV-1 protease using 125 I-SPA (scintillation proximity assay)More data for this Ligand-Target Pair
Affinity DataIC50: 850nMAssay Description:Compound was evaluated for its inhibitory activity in recombinant HIV-l proteaseMore data for this Ligand-Target Pair
Affinity DataIC50: 870nMAssay Description:Concentration required for inhibitory activity against HIV-1 ProteaseMore data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+3nMAssay Description:Inhibitory activity against HIV-1 proteaseMore data for this Ligand-Target Pair
Affinity DataIC50: 1.20E+3nMAssay Description:Compound was evaluated for its inhibitory activity in recombinant HIV-l proteaseMore data for this Ligand-Target Pair
Affinity DataIC50: >1.40E+3nMAssay Description:Concentration required for inhibitory activity against HIV-1 ProteaseMore data for this Ligand-Target Pair
Affinity DataIC50: >1.40E+3nMAssay Description:Concentration required for inhibitory activity against HIV-1 ProteaseMore data for this Ligand-Target Pair
Affinity DataIC50: 2.00E+3nMAssay Description:Inhibitory activity against HIV-1 proteaseMore data for this Ligand-Target Pair
Affinity DataIC50: 3.00E+3nMAssay Description:Compound was tested for inhibitory activity against recombinant HIV-1 protease using 125 I-SPA (scintillation proximity assay)More data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+4nMAssay Description:Compound was tested for inhibitory activity against recombinant HIV-1 protease using 125 I-SPA (scintillation proximity assay)More data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibitory activity against HIV-1 proteaseMore data for this Ligand-Target Pair
Affinity DataIC50: 4.00E+4nMAssay Description:Compound was evaluated for its inhibitory activity against recombinant HIV-1 protease using [125I]-SPA (scintillation proximity assay)More data for this Ligand-Target Pair
TargetPolymerase basic protein 2(Influenza A virus (strain A/Puerto Rico/8/1934 H1N...)
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataKd: 70nMAssay Description:Binding affinity to influenza A virus (A/Puerto Rico/8/1934(H1N1)) PB2 by competition binding fluorescence polarization (FP) assayMore data for this Ligand-Target Pair
TargetPolymerase basic protein 2(Influenza A virus (strain A/Puerto Rico/8/1934 H1N...)
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataKd: <3nMAssay Description:Binding affinity to full length Influenza A virus PB2 cap-binding domain assessed as dissociation constant incubated for 60 mins by fluorescence pola...More data for this Ligand-Target Pair
Ligand Info
TargetPolymerase basic protein 2(Influenza A virus (strain A/Puerto Rico/8/1934 H1N...)
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataKd: 400nMAssay Description:Binding affinity to influenza A virus (A/Puerto Rico/8/1934(H1N1)) PB2 by competition binding fluorescence polarization (FP) assayMore data for this Ligand-Target Pair
TargetPolymerase basic protein 2(Influenza A virus (strain A/Puerto Rico/8/1934 H1N...)
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataKd: 200nMAssay Description:Binding affinity to influenza A virus (A/Puerto Rico/8/1934(H1N1)) PB2 by competition binding fluorescence polarization (FP) assayMore data for this Ligand-Target Pair
TargetPolymerase basic protein 2(Influenza A virus (strain A/Puerto Rico/8/1934 H1N...)
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataKd: 400nMAssay Description:Binding affinity to influenza A virus (A/Puerto Rico/8/1934(H1N1)) PB2 by competition binding fluorescence polarization (FP) assayMore data for this Ligand-Target Pair
TargetPolymerase basic protein 2(Influenza A virus (strain A/Puerto Rico/8/1934 H1N...)
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataKd: 30nMAssay Description:Binding affinity to influenza A virus (A/Puerto Rico/8/1934(H1N1)) PB2 by competition binding fluorescence polarization (FP) assayMore data for this Ligand-Target Pair
TargetPolymerase basic protein 2(Influenza A virus (strain A/Puerto Rico/8/1934 H1N...)
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataKd: <2nMAssay Description:Binding affinity to influenza A virus (A/Puerto Rico/8/1934(H1N1)) PB2 by competition binding fluorescence polarization (FP) assayMore data for this Ligand-Target Pair
TargetPolymerase basic protein 2(Influenza A virus (strain A/Puerto Rico/8/1934 H1N...)
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataKd: <2nMAssay Description:Binding affinity to influenza A virus (A/Puerto Rico/8/1934(H1N1)) PB2 by competition binding fluorescence polarization (FP) assayMore data for this Ligand-Target Pair
TargetPolymerase basic protein 2(Influenza A virus (strain A/Puerto Rico/8/1934 H1N...)
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataKd: <2nMAssay Description:Binding affinity to influenza A virus (A/Puerto Rico/8/1934(H1N1)) PB2 by competition binding fluorescence polarization (FP) assayMore data for this Ligand-Target Pair